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Abstract
Background: Microbial exposures have been suggested to confer protection from allergic disorders and reduced exposures
to gastrointestinal microbiota have been proposed as an explanation for the increase in asthma prevalence. Since the
general prevalence of Helicobacter pylori has been decreasing, we hypothesized that H. pylori serostatus would be inversely
related to the presence of asthma.
Methods: Adults were recruited to participate in the New York University (NYU)/Bellevue Asthma Registry in New York City.
Adult asthma cases (N=318) and controls (N=208) were identified and serum IgG antibodies to H. pylori whole cell antigens
or the immunodominant CagA antigen were measured.
Results: As expected, the asthma cases and controls differed with respect to atopy and lung function. Seropositivity to H.
pylori or CagA antigen was present in 47.1% of the total case and control study population. Asthma was inversely associated
with CagA seropositivity (OR=0.57, 95% CI=0.36–0.89). Median age of onset of asthma (doctor’s diagnosis) was older (21
years) among individuals with CagA+ strains than among H. pylori- individuals (11 years) (p=0.006).
Conclusion: These data are consistent with the hypothesis that colonization with CagA+ H. pylori strains is inversely
associated with asthma and is associated with an older age of asthma onset in an urban population. The data suggest H.
pylori as a marker for protection.
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Introduction
The prevalence of atopy and asthma has increased worldwide
[1]. The ‘‘hygiene hypothesis,’’ that reduced childhood exposure
to microorganisms modifies polarized Th1/Th2 responses leading
to more allergic disorders, has been proposed to explain this
increase [2]. Relevant microbial exposures may include gastroin-
testinal biota. Intestinal microbiota differ between healthy infants
in countries with low or high allergy prevalence, as well as between
allergic and non-allergic infants [3]. Early exposure to orofecal
microbes such as Hepatitis A, appears to protect against allergen
sensitization [4–7], and in Italian military recruits and Danish
adults, HAV, Toxoplasma gondii, and Helicobacter pylori, are inversely
associated with atopy [8,9].
H. pylori, gram-negative, microaerophilic gastric bacteria persis-
tently colonize much of the world’s population. Whereas nearly all
adults are H. pylori-positive in developing countries, with socioeco-
nomic development, prevalence has decreased substantially [10,11].
H. pylori is almost exclusively acquired in childhood [12,13] and
antibodyresponsesarepresentfordecades orforlife,consistentwith
the persistent gastric colonization [10,11,14]. H. pylori virulence is
affected bythepresenceofthe35-40-kb cagpathogenicityisland that
can be detected by identification of the cagA gene or its product
(CagA) [15]. CagA+ strains are more host-interactive [15,16]. H.
pyloricolonization inducescontinuousgastricinflammation,whichis
more pronounced with cagA+ strains [17], and leads toward
diminished gastric acidity [18]. Serologic assays to detect antibodies
to the CagA protein enhance overall detection of H. pylori,a n d
specifically detection of the more interactive (CagA+) organisms
[19]. Antibodies to CagA persist for at least two decades in the
absence of antimicrobial treatments that eliminate H. pylori [14].
We hypothesized that the presence of H. pylori antibodies would
be inversely related to asthma and that cagA+ strains of H. pylori
would have a more pronounced inverse relationship with asthma.
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Sweden suggested an inverse association of antibodies to H. pylori
and self-reported hay fever or asthma [20]. In the NHANES III
population, we demonstrated an inverse association of ever having
had asthma with a cagA+ H. pylori strain [21] and in the NHANES
IV population, in which CagA testing was not done, we found
inverse associations of H. pylori status with childhood-onset asthma
and allergic disorders [22]. We now provide evidence showing an
inverse association of CagA serology with asthma in a case control
study of an additional well-characterized and separate adult urban
population.
Methods
Study population
Asthma cases and non-asthma controls were recruited to
participate in the New York University (NYU)/Bellevue Asthma
Registry in New York City. The registry was approved by the
Institutional Review Board of the New York University School of
Medicine. All cases and controls signed informed consent. Letters
informing patients of positive H. pylori serology were sent under an
IRB-approved protocol. Cases were referred to the registry by the
Bellevue Hospital Center Asthma Clinic and local clinics. Controls
were referred by asthma cases and by enlisting individuals directly
from the community and from other programs within Bellevue
Hospital Center. A number of referrals from the cases were
unintentionally genetically related and these individuals were
accounted for in the statistical methods. Cases and controls were
excluded if they were ,18 or $65 years old; were current
smokers; had a history of .10 pack-year tobacco use; or had an
unstable cardiac disease, uncontrolled hypertension, lung disease
other than asthma, or neuromuscular disease.
Questionnaires and evaluations were completed for 573
persons. Subjects were considered to have a diagnosis of ‘‘asthma’’
based on their response to questions derived from validated
questionnaires [23,24] used for international studies of asthma. All
patients were seen by a physician or nurse with extensive
experience in asthma diagnoses and management. Because most
of these adult patients were using chronic medication for asthma
or had longstanding disease, a 12% change in FEV1 was not used
as a criterion for diagnosis. We confirmed our diagnosis with the
published algorithm of Enright et al. [25]. Twelve persons who
could not be classified as either having asthma or being asthma-
free and 35 individuals without serum samples were excluded from
statistical analyses. Race and ethnicity were self-classified. The
final study population included 526 subjects (318 asthma cases and
208 controls).
Serum antibody analysis
Serum anti-H. pylori IgG antibody levels were determined by
ELISA using whole cell antigens [19]. CagA status was determined
by a separate ELISA, based on the presence of serum IgG
antibodies against orv220, a 65 kDa recombinant CagA truncated
protein [19,26]. Absence of H. pylori was defined as negativity in
both the whole cell and CagA assays (H. pylori negative).
Individuals were defined as colonized with cagA negative H. pylori
strains if they had antibodies to the whole cell antigen but not to
CagA (H. pylori+/CagA2). Subjects were defined as being
colonized with cagA+ H. pylori strains if they were positive for
CagA antibodies, whether or not they were positive for H. pylori
antibodies (CagA+). Thirty one persons (5.9%) were CagA+ but
had H. pylori serological determinations that did not reach positive
values, a finding consistent with previous studies in H. pylori
culture-positive subjects [27].
Allergy testing
Measurements of total serum IgE (total IgE) and allergen-
specific IgE for allergens considered significant for the Northeast-
ern United States were performed in a commercial laboratory
(Pharmacia ImmunoCAP assay; Quest Diagnostics; Teterboro,
NJ). Allergen results were available for 525 of the 526 subjects. An
allergen-specific IgE level .0.35 kilo-international units (kIU)/L
was considered positive.
Spirometry
Pre- and post-bronchodilator spirometry was performed
according to American Thoracic Society guidelines [28]; normal
values were obtained from Hankinson et al. [29]. Values were
obtained on 516 subjects, but were not available for 10 subjects.
Statistical Methods
Non-parametric Wilcoxon and Kruskall-Wallis tests were used
for crude comparisons of quantitative variables among groups, and
the chi-squared test used for comparisons of categorical variables.
In multivariable analyses, generalized estimating equations (GEE)
were used to confirm the findings because of the presence of
matched sets of individuals that occurred when asthma cases
referred family members to the study. Data from genetically
related cases and controls (n=104) were entered as ‘‘repeated
measures’’ in GEE logistic and linear regression analyses to
account for the potentially correlated nature of observations
among related individuals [30]. GEE was used with a logit link for
logistic regression analyses of risk factors for asthma; risk factors
for allergen-specific IgE, and separately, for seropositivity to either
cagA2 or cagA+ strains of H. pylori. In multivariable analyses, we
first included all potential confounders in models and then
dropped from the models those potential confounders that did
not substantially affect the odds ratios of the variables of interest.
GEE analyses were conducted using SAS 9.1 Proc GENMOD
(SAS Institute Inc., Cary, NC, USA, 2002). Kaplan-Meier
estimation and Cox proportional hazards regression were used
to investigate correlates of age of diagnoses of asthma.
Results
Characteristics of the study groups
Characteristics of the asthma cases and non-asthma controls are
shown in Table 1. Cases and controls were similar in age and
gender. Cases were more often Hispanic, and income levels were
lower in the cases than in the controls. Hispanic ethnicity was not
associated with asthma status, once income and race were adjusted
for via logistic regression. As expected, total IgE was elevated in
the cases compared to the controls, and there was a significant
association of asthma with atopy, as defined by the presence of at
least one allergen-specific IgE. Lung function parameters including
post-bronchodilator forced expiratory volume in one second
(FEV1), post-bronchodilator forced vital capacity (FVC), and the
ratio of FEV1/FVC were reduced in the cases compared to
controls. These characteristics are consistent with expectations for
an asthma population compared to a control population.
H. pylori status and asthma
Table 2 shows the crude and adjusted odds ratios (OR) for
asthma and H. pylori serostatus. Although there was a suggestion
of an association of asthma with CagA+ status, the crude OR for
asthma associated with H. pylori+/CagA2 or CagA+ status failed
reach significance. In contrast, after adjustment for race and
income, there was a significant inverse association of asthma and
CagA+ status with an OR of 0.63 (95% CI=0.41–0.98). We also
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using GEE logistic regression analysis to adjust for age, race,
Hispanic ethnicity, income, and the genetic relatedness among
some of the subjects (Table 3). As expected, atopy was associated
with asthma. The significant inverse association of CagA+ status
with asthma was again demonstrated (OR=0.57, 95% CI=0.36–
0.89). Analyses that treated all subjects as independent also yielded
similar results (data not shown). We also repeated the analyses
limiting subjects to those who were neither genetically related nor
referred by one another (N=402). Unconditional logistic regres-
sion in this group, adjusted for age, income, education, race/
ethnicity, and atopy continued to yield an inverse association of
asthma with CagA+ status (OR=0.49, 95% CI=0.28–0.85). The
inverse OR associated with CagA+ status also was not substantially
altered when atopy was excluded from the model. Inclusion of
variables representing presence of allergen-specific IgE antibodies
or of log10IgE in the multiple logistic regression model for asthma
also had no major impact on our primary finding of an inverse
association with CagA+ H. pylori strains.
H. pylori as an asthma modifier
We examined the relationship between H.pylori serostatus and
IgE. Log10IgE was not associated with either H. pylori+/CagA2
status or CagA+ status after adjustment for differences in race,
Hispanic ethnicity, and age (GEE, data not shown). No
relationship was identified between atopy, and either H. pylori+/
CagA2 status or CagA+ status. Among atopic subjects (N=356),
19.7% were H. pylori+/CagA2 and 27.3% were CagA+, whereas
among non-atopic subjects (N=169), 19.3% were H. pylori+/
CagA2 and 27.8% were CagA+ (p=0.99). Atopy also was not
associated with H. pylori status in a multivariable GEE logistic
regression model that included adjustments for race, Hispanic
ethnicity, education and income. Similarly, atopy was not
associated with H. pylori status in the control population (p=0.8).
In addition, we examined whether H. pylori serostatus was an
asthma modifier using post-bronchodilator FEV1 and FEV1/FVC
as surrogates of asthma severity. There was a significant difference
in FEV1 among the individuals with asthma who were CagA+
(N=76, median % predicted=82.0 (interquartile range,
IQR=71–92) compared to those who were H. pylori negative
(N=170, median % predicted=90.0, IQR=77–100) (p=0.008),
although FEV1/FVC was not different between the two groups
(median=80.0% predicted, IQR=74.0–86.5 in CagA+ subjects
and 82.0%, IQR=76–85 in H. pylori2 subjects) (p=0.4).
We next asked whether H. pylori serostatus was associated with
the age of onset of asthma. Age of onset of asthma was similar
among the H. pylori+/CagA2 individuals (N=64, median
Table 1. Characteristics of the case control study population.
Characteristic
Asthma cases
(N=318)
Controls
(N=208)
Crude Odds
ratio (95% CI)
Adjusted* Odds
ratio (95% CI) p-value{
Age–year (median, IQR) 34 (18–64) 38 (18–64) 0.4
Sex - no. (%)
Male 95 (29.9) 69 (33.2) 1.0
Female 223 (70.1) 139 (66.8) 1.17 (0.8–1.7) 0.97 (0.7–1.4)
Race–no. (%)
White 239 (75.2) 123 (59.1) 1.0 1.0
Black 53 (16.7) 40 (19.2) 0.68 (0.42–1.1) 0.70 (0.43–1.1)
Asian and other 26 (8.2) 45 (21.6) 0.29 (0.17–0.52) 0.35 (0.20–0.61)
Hispanic ethnicity–no. (%)
No 130 (40.9) 131 (63.0) 1.0 1.0
Yes 188 (59.1) 77 (37.0) 2.5 (1.7–3.6) 1.4 (0.8–2.2)
Yearly income–no. (%)
,15 K 132 (41.5) 40 (19.2) 1.0 1.0
15–49 K 82 (25.8) 64 (30.8) 0.39 (0.23–0.65) 0.39 (0.24–0.63)
50–99 K 43 (13.5) 56 (26.9) 0.23 (0.13–0.41) 0.26 (0.15–0.45)
$100 K 11 (3.5) 19 (9.1) 0.18 (0.07–0.43) 0.20 (0.09–0.47)
No response or refused 50 (15.7) 29 (13.9) 0.52 (0.28–0.97) 0.54 (0.30–0.98)
Atopic status
a - no. (%)
Non-atopic 74 (23.3) 95 (45.9) 1.0
Atopic 244 (76.7) 112 (54.1) 2.80 (1.9–4.2) 3.4 (2.2–5.0)
Total IgE - U/ml (median, IQR) 129 (40–386) 42 (15–140) ,0.0001{
Spirometry - % predicted (median, IQR)
Post bd FEV1 86 (74–97) 92 (85–101) ,0.0001
Post bd FVC 88 (78–98) 91 (82–100) ,0.02
Post bd FEV1/FVC 81 (75–85) 85 (81–87) ,0.0001
{p-values are from the Wilcoxon test and are provided for quantitative variables.
*Adjusted for income (using 5 categories shown in table) and race via logistic regression.
aAtopy defined as presence of any allergen-specific IgE at a level .35 kIU/L.
doi:10.1371/journal.pone.0004060.t001
Asthma and H. pylori
PLoS ONE | www.plosone.org 3 December 2008 | Volume 3 | Issue 12 | e4060age=19, IQR=6–30) and the CagA+ individuals (N=71, median
age=21, IQR=8–34), but was substantially lower among the H.
pylori negative individuals (N=159, median age=11 y, IQR=5–23)
(p=0.006). Similar differences in age were noted when we assessed
age at onset of symptoms (data not shown). We performed
Kaplan-Meier analysis of the probability of age-related survival
until a doctor’s diagnosis of asthma (Figure 1) assuming that
acquisition of H. pylori occurred close to the time of birth, as
suggested in the literature [13,17,31,32]. Cox regression analysis
adjusted for age and income (adjustment for race/ethnicity did not
affect the results of this analysis) suggested a reduced hazard ratio
(HR) in CagA+ individuals compared to H. pylori2 individuals
(HR=0.74, 95% CI=0.54–1.02) whereas the HR for H. pylori+/
CagA2 individuals compared to H. pylori2 individuals was not
substantially different from 1 (HR=0.93, 95% CI=0.67–1.29).
We further modeled ages at doctor’s diagnosis of asthma by GEE
to take into account potentially correlated times of diagnosis
among genetically related family members and to adjust for
potential confounders. This analysis showed a significantly greater
age at doctor’s diagnosis of asthma among CagA+ subjects
compared with H. pylori-negative subjects (p=0.02).
Discussion
Reduced exposure to orofecal organisms has been suggested as
an explanation for the increasing prevalence of atopy and asthma,
but studies of multiple organisms have had conflicting results [5].
We studied a racially and ethnically diverse urban population in a
case control study to examine the relationship between asthma
and H. pylori serostatus. H. pylori seroprevalence was common in
both cases and controls, in accordance with national estimates
[33]. Our analysis identified a trend towards an inverse association
between H. pylori and asthma that became significant when we
examined individuals who carried cagA+ H. pylori strains. Our
data provide evidence that in an urban population, asthma is
inversely associated with serologic evidence of the presence of
cagA+ H. pylori strains. We used several different analytical
approaches, and analytical results were highly consistent. Our
findings support and expand upon our recent cross-sectional study
of separate populations of individuals with an asthma diagnosis in
the NHANES III and NHANES IV populations [21,22], and now
include subjects with spirometry and serum IgE determinations.
Our analysis of age of onset of disease in an adult population, in
which we detect a delay on onset of asthma in CagA+ individuals,
is consistent with the age relationships reported in the two
NHANES populations.
We did not detect an effect of H. pylori serostatus on total IgE or
the presence of atopy in our population. This finding suggests that
the ability of H. pylori exposure to modify asthma may be mediated
via mechanisms other than those associated with IgE levels.
Interestingly, although we detected a delay in the onset of asthma
associated with the presence of CagA+ serology, FEV1 was
reduced in this group. The finding of reduced lung function in
individuals with a later age of onset of asthma is consistent with
those recently reported [34–36].
Potential mechanisms by which H. pylori could alter asthma
presentation include immune modifications or an effect on gastro-
esophageal reflux disease (GERD). Although H. pylori colonization
recruits neutrophils, T and B lymphocytes and macrophages to the
stomach [17], H. pylori generally persists for the host’s lifetime [37],
reflecting immune evasion and modification of host inflammatory,
innate, and adaptive immune responses [10,12,38,39]. H. pylori
may alter the polarized Th1/Th2 T cell response through
dendritic cell-mediated T-cell expression of IL-12, TNF-a, and
IFN-c [40–42], and cagA translocation induces IL-12 production
[43]. H. pylori colonization induces regulatory T cells including
CD4
+ CD25
+ T cells that express the forkhead box P3
transcription factor (Foxp3) [44,45] and also induces indoleamine
2,3-dioxygenase, mechanisms that suppress T cell function [46].
IL-10 expression is increased in the gastric mucosa of children
carrying H. pylori [47]. Such immunosuppressive and immuno-
modulatory effects have the potential to alter the effector phase of
asthma as recently shown in murine models of helminth infection
[48]. Helicobacter pylori upregulate Toll-like receptor 4 (TLR4) [49],
and although results are complex, human and murine studies
suggest that activation of TLR4 may be protective against allergic
asthma [50].
Associations between GERD and asthma also are well-
established [51–53]. Longitudinal studies show that asthma is a
risk factor for development of GERD, and that GERD can trigger
asthma [51–53]. H. pylori, especially cagA+ strains, are inversely
associated with GERD [12,54]. Although we did not specifically
assess for GERD in this study, the possibility exists that the inverse
association between H. pylori and asthma reflects protection from
GERD.
Table 2. Association between H. pylori serostatus and asthma in asthma cases (N=318) and non-asthma controls (N=208).
Asthma cases N (%) Controls N (%) Crude OR (95% CI) Adjusted* OR (95% CI)
H. pylori status
H. pylori2/CagA2 171 (53.8) 108 (51.9) 1.0 1.0
H. pylori+/CagA2 68 (21.4) 35 (16.8) 1.23 (0.74–2.03) 0.94 (0.57–1.57)
CagA+ 79 (24.8) 65 (31.3) 0.77 (0.50–1.18) 0.63 (0.41–0.98)
*Adjusted for income (using 5 categories shown in Table 1) and race (white, black, other) via logistic regression.
doi:10.1371/journal.pone.0004060.t002
Table 3. Association between H. pylori status or atopy and
asthma using generalized estimating equation (GEE) multiple
logistic regression analysis (N=525).
Risk factor Value OR
a 95% CI p-value
H. pylori status H. pylori2 1.0 –
H. pylori+/CagA2 0.74 (0.41–1.3) 0.39
CagA+ 0.57 (0.36–0.89) 0.02
Atopy
b No 1.0 –
Yes 3.39 (2.20–5.20) ,0.0001
aMultivariate analysis performed using GEE and adjusted for age (in years),
education (in years), income, race (white, black, other) and Hispanic ethnicity.
bAtopy defined as any allergen-specific IgE.
doi:10.1371/journal.pone.0004060.t003
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seronegativity is a surrogate for other phenomena such as the
presence or absence of other indigenous biota, or merely reflects
cumulative early life exposure to antibiotics, identified as a risk
factor for asthma. Although possible, the specificity of the
relationship to cagA+ strains argues against this point. There are
some potential limitations to this study. Although we do not know
the age at which H. pylori was acquired in the cases or controls,
multiple studies have demonstrated that nearly all acquisition that
occurs does so at an early age, usually before the age of five
[12,13]. H. pylori antibodies reflect the present carriage of H. pylori,
and its prior elimination due to antibiotic exposure could lead to
seronegativity. Thus, the current serostatus could under-estimate
H. pylori acquisition, but not persistence, since with long-term
carriage of H. pylori, antibody levels are stable [12,15].
One potential confounding factor could be greater antibiotic use
in asthma cases than in controls, which would bias toward
consequent elimination of H. pylori. The association of the inverse
association with childhood-onset but not later-age onset asthma in
this study (Figure 1), and two other recent studies [21,22] as well as
the specificity of the effect with cagA
+ positivity argues against that
point. However, prospective studies will be needed to clarify this
question.
Because adults were studied, the association of H. pylori with
delay in asthma onset may be confounded by recall bias or delay in
doctor diagnosis. Although these issues suggest the need for future
prospective studies, our findings support those of our recent cross-
sectional studies of NHANES populations [21,22].
In conclusion, our data suggest that H. pylori, and specifically,
CagA positivity is inversely associated with asthma and with a
delay in the onset of asthma. That the association was strongest
with cagA+ H. pylori strains suggests that the more intensive host-
interaction of these organisms may influence disease expression.
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